00:00<\/b> \"India Examining Strategy\": Centre On Pfizer Covid Vaccine Constraints<\/font>

<\/div>
The cold-chain requirement for the anti-coronavirus vaccine candidate developed by Pfizer at a temperature of minus 70 degrees Celsius poses a big challenge, but the government is examining the possibilities if at all the vaccine has to be obtained by India, it said on Tuesday.<\/div>

<\/div>
The government further said a national scheme on COVID-19 vaccine distribution is in its final stages of preparation.<\/div>

<\/div>
At a press briefing, NITI Aayog member (Health) Dr VK Paul, who also heads the National Task Force on COVID-19, said sufficient doses of the vaccine, as required for the Indian population, will not be available, but the government is looking at the possibilities and will work out a strategy for its procurement and distribution in case it gets the regulatory approvals.<\/div>

<\/div>
Mr Paul, however, reminded that the arrival of the Pfizer vaccine in the country might take some months.<\/div>

<\/div>
\"The arrangement of cold-chains for storing the vaccine developed by Pfizer at a low temperature of minus 70 degrees Celsius is a big challenge and it will not be easy for any nation. But then, if at all it has to be obtained, we are examining what we need to do...and will work out a strategy,\" he said.<\/div><\/div>","entype":"Text","h":"","img":"","imgalt":"","imgcaption":"","key":"False","link":"","s":2,"sub":"","t":"Nov 18, 2020-06:46:27","title":"

<\/div>
The cold-chain requirement for the anti-coronavirus vaccine candidate developed by Pfizer at a temperature of minus 70 degrees Celsius poses a big challenge, but the government is examining the possibilities if at all the vaccine has to be obtained by India, it said on Tuesday.<\/div>

<\/div>
The government further said a national scheme on COVID-19 vaccine distribution is in its final stages of preparation.<\/div>

<\/div>
At a press briefing, NITI Aayog member (Health) Dr VK Paul, who also heads the National Task Force on COVID-19, said sufficient doses of the vaccine, as required for the Indian population, will not be available, but the government is looking at the possibilities and will work out a strategy for its procurement and distribution in case it gets the regulatory approvals.<\/div>

<\/div>
Mr Paul, however, reminded that the arrival of the Pfizer vaccine in the country might take some months.<\/div>

<\/div>
\"The arrangement of cold-chains for storing the vaccine developed by Pfizer at a low temperature of minus 70 degrees Celsius is a big challenge and it will not be easy for any nation. But then, if at all it has to be obtained, we are examining what we need to do...and will work out a strategy,\" he said.<\/div>","type":"nfeed"});